Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthcare Services (HCSG) EBITDA (2016 - 2025)

Healthcare Services (HCSG) has disclosed EBITDA for 17 consecutive years, with $31.5 million as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA rose 211.3% to $31.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $75.5 million, a 11.58% increase, with the full-year FY2025 number at $60.9 million, up 56.23% from a year prior.
  • EBITDA was $31.5 million for Q4 2025 at Healthcare Services, up from $17.7 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $31.5 million in Q4 2025 to a low of -$8.1 million in Q3 2023.
  • A 5-year average of $12.0 million and a median of $10.3 million in 2021 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: tumbled 308.47% in 2023, then surged 300.26% in 2024.
  • Healthcare Services' EBITDA stood at $4.8 million in 2021, then skyrocketed by 270.57% to $17.8 million in 2022, then surged by 48.53% to $26.4 million in 2023, then plummeted by 61.7% to $10.1 million in 2024, then soared by 211.3% to $31.5 million in 2025.
  • Per Business Quant, the three most recent readings for HCSG's EBITDA are $31.5 million (Q4 2025), $17.7 million (Q1 2025), and $10.1 million (Q4 2024).